These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10574262)

  • 21. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.
    Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR
    Br J Cancer; 2000 Nov; 83(9):1147-53. PubMed ID: 11027427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
    Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients.
    Beppu K; Uchiyama A; Morisaki T; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2001; 21(3C):2195-200. PubMed ID: 11501846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line.
    To Y; Dohi M; Matsumoto K; Tanaka R; Sato A; Nakagome K; Nakamura T; Yamamoto K
    Am J Respir Cell Mol Biol; 2002 Aug; 27(2):220-6. PubMed ID: 12151314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatocyte growth factor (HGF) in fluid from operation fields of breast surgery].
    Asaga T; Sugimasa Y; Takemiya S; Suzuki K; Yanoma S
    Gan To Kagaku Ryoho; 1998 May; 25(6):834-43. PubMed ID: 9617322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
    Bredin CG; Liu Z; Klominek J
    Anticancer Res; 2003; 23(6C):4877-84. PubMed ID: 14981939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.
    Shimizu K; Yoshida J; Nagai K; Nishimura M; Yokose T; Ishii G; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1574-8. PubMed ID: 15173709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
    Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.
    Nayeri F; Olsson H; Peterson C; Sundqvist T
    J Dermatol Sci; 2005 Feb; 37(2):75-85. PubMed ID: 15659325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
    Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
    Murakami N; Koufuji K; Shirouzu K
    Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.